Literature DB >> 24111356

Analysis of endocardial acceleration during intraoperative optimization of cardiac resynchronization therapy.

Alfredo I Hernandez, Filippo Ziglio, Amel Amblard, Lotfi Senhadji, Christophe Leclercq.   

Abstract

Cardiac resynchronization therapy (CRT) is the therapy of choice for selected patients suffering from drug-refractory congestive heart failure and presenting an interventricular desynchronization. CRT is delivered by an implantable biventricular pacemaker, which stimulates the right atrium and both ventricles at specific timings. The optimization and personalization of this therapy requires to quantify both the electrical and the mechanical cardiac functions during the intraoperative and postoperative phases. The objective of this paper is to evaluate the feasibility of the calculation of features extracted from endocardial acceleration (EA) signals and the potential utility of these features for the intraoperative optimization of CRT. Endocardial intraoperative data from one patient are analyzed for 33 different pacing configurations, including changes in the atrio-ventricular and inter-ventricular delays and different ventricular stimulation sites. The main EA features are extracted for each pacing configuration and analyzed so as to estimate the intra-configuration and inter-configuration variability. Results show the feasibility of the proposed approach and suggest the potential utility of EA for intraoperative monitoring of the cardiac function and defining optimal, adaptive pacing configurations.

Entities:  

Mesh:

Year:  2013        PMID: 24111356      PMCID: PMC3900433          DOI: 10.1109/EMBC.2013.6611169

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  7 in total

1.  PEA I and PEA II based implantable haemodynamic monitor: pre clinical studies in sheep.

Authors:  G Plicchi; E Marcelli; M Parlapiano; T Bombardini
Journal:  Europace       Date:  2002-01       Impact factor: 5.214

2.  2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.

Authors:  Kenneth Dickstein; Panos E Vardas; Angelo Auricchio; Jean-Claude Daubert; Cecilia Linde; John McMurray; Piotr Ponikowski; Silvia Giuliana Priori; Richard Sutton; Dirk J van Veldhuisen
Journal:  Europace       Date:  2010-11       Impact factor: 5.214

3.  A comparison of acoustic cardiography and echocardiography for optimizing pacemaker settings in cardiac resynchronization therapy.

Authors:  Michel Zuber; Stefan Toggweiler; Lori Quinn-Tate; Lei Brown; Ali Amkieh; Paul Erne
Journal:  Pacing Clin Electrophysiol       Date:  2008-07       Impact factor: 1.976

4.  Optimal algorithm switching for the estimation of systole period from cardiac microacceleration signals (SonR).

Authors:  L Giorgis; P Frogerais; A Amblard; E Donal; P Mabo; L Senhadji; A I Hernández
Journal:  IEEE Trans Biomed Eng       Date:  2012-08-07       Impact factor: 4.538

Review 5.  Digital signal processing of the phonocardiogram: review of the most recent advancements.

Authors:  L G Durand; P Pibarot
Journal:  Crit Rev Biomed Eng       Date:  1995

6.  Endocardial acceleration (sonR) vs. ultrasound-derived time intervals in recipients of cardiac resynchronization therapy systems.

Authors:  Erwan Donal; Lionel Giorgis; Serge Cazeau; Christophe Leclercq; Lotfi Senhadji; Amel Amblard; Gael Jauvert; Marc Burban; Alfredo Hernández; Philippe Mabo
Journal:  Europace       Date:  2011-01-06       Impact factor: 5.214

7.  Accelerometer-derived time intervals during various pacing modes in patients with biventricular pacemakers: comparison with normals.

Authors:  Frank I Marcus; Vincent Sorrell; John Zanetti; Mike Bosnos; Gurpreet Baweja; Doug Perlick; Peter Ott; Julia Indik; Ding Sheng He; Kathy Gear
Journal:  Pacing Clin Electrophysiol       Date:  2007-12       Impact factor: 1.976

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.